Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 35,176 shares at $85.06 ($3.0M) on 2025-09-30, disclosed to the SEC on 2025-10-01.
Scheduled sale ($3.0M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.01 | 7,588 | $645K | 21.6% |
| 2 | $85.01 | 7,588 | $645K | 21.6% |
| 3 | $85.06 | 20,000 | $1.7M | 56.9% |
| Total | $85.04 avg | 35,176 | $3.0M | 100% |
| Filing → |
| NUVL | SELL | 2026-05-05 | $1.1M | — | Filing → |
| NUVL | SELL | 2026-04-03 | $1.2M | — | Filing → |
| NUVL | SELL | 2026-03-26 | $2.5M | — | Filing → |